Individualized Dose-Response to Statins Associated With Cardiovascular Disease Outcomes
Aggarwal S, Jiang L, Liu G, Grabowska M, Ong H, Wilke R, Feng Q, Wei W. Individualized Dose-Response to Statins Associated With Cardiovascular Disease Outcomes. JACC Advances 2024, 3: 100894. PMID: 38737008, PMCID: PMC11086740, DOI: 10.1016/j.jacadv.2024.100894.Peer-Reviewed Original ResearchAtherosclerotic cardiovascular diseaseAtherosclerotic cardiovascular disease eventsLDL-CComposite primary end pointPrevention of atherosclerotic cardiovascular diseaseDose responseLow-density lipoprotein cholesterolBaseline LDL-CPrimary end pointAll-Cause MortalityElectronic health record dataTime-to-event analysisHealth record dataCardiovascular disease outcomesIndividual dose responsesMultiple dosesClinical outcomesPrescribed statinsLipoprotein cholesterolHazard ratioStatinsEnd pointsDisease outcomeCardiovascular diseaseED50
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply